Qube Research & Technologies LTD Moderna, Inc. Call Options Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $10.5 Million - $20.6 Million	164,900 Added 184.45%	254,300 $17 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $6.16 Million - $10.1 Million	60,900 Added 213.68%	89,400 $10.6 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $6.59 Million - $8.91 Million	-77,200 Reduced 73.04%	28,500 $3.04 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $1.42 Million - $2.14 Million	-20,500 Reduced 16.24%	105,700 $10.5 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $12.2 Million - $16 Million	126,200 New	126,200 $13 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.